Invesco S&P 500 Equal Weight Health Care ETF
  • RSPH

  • $31.74

  • -0.50%
  • $31.90

  • $31.97

  • $31.74

Prices as of 2025-12-02 16:20:44 ET

Ticker Appearances

Daily Technical Strategy
Mon, November 24, 2025 | 7:07PM ET

Medical Device names now breaking out to join Biotechnology

NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...

Unlock full access to Fundstrat’s research — now at our lowest price of 2025.

You’ve reached your 2 free reports this month.

Visitor: 71b972-882d9a-594ccd-45b3ff-b760f8

Live Technical Stock Analysis
Tue, November 18, 2025 | 8:39PM ET
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.

You’ve reached your 2 free reports this month.

Visitor: 71b972-882d9a-594ccd-45b3ff-b760f8

Technical Strategy
Mon, October 20, 2025 | 6:20PM ET
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.

You’ve reached your 2 free reports this month.

Visitor: 71b972-882d9a-594ccd-45b3ff-b760f8

Live Technical Stock Analysis
Mon, October 13, 2025 | 8:50PM ET
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.

You’ve reached your 2 free reports this month.

Visitor: 71b972-882d9a-594ccd-45b3ff-b760f8

Daily Technical Strategy
Thu, October 2, 2025 | 10:47AM ET

SPX, RSP, RSPH and Gold/Bitcoin Ratio in Focus

^SPX has now pushed back to new all-time high territory this week, which sets up for a push up to 6749 in the short run,...

Unlock full access to Fundstrat’s research — now at our lowest price of 2025.

You’ve reached your 2 free reports this month.

Visitor: 71b972-882d9a-594ccd-45b3ff-b760f8

Daily Technical Strategy
Thu, September 25, 2025 | 6:57PM ET

Biotechnology looks like what to favor in a deteriorating Healthcare sector

NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, BUT TUESDAY’S SETBACK MIGHT HAVE KICKED OFF THE START OF A MINOR PULLBACK IN STOCK...

Unlock full access to Fundstrat’s research — now at our lowest price of 2025.

You’ve reached your 2 free reports this month.

Visitor: 71b972-882d9a-594ccd-45b3ff-b760f8

Events

Trending tickers in our research

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You are reading the last free article for this month.

By continuing, you agree to the Terms of Service and Privacy Policy.

Already have an account? Sign In